Hussman Strategic Advisors Inc. bought a new stake in shares of The Cigna Group (NYSE:CI - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 10,500 shares of the health services provider's stock, valued at approximately $2,899,000. The Cigna Group accounts for approximately 0.9% of Hussman Strategic Advisors Inc.'s portfolio, making the stock its 24th largest holding.
Other large investors have also bought and sold shares of the company. Prospera Private Wealth LLC bought a new stake in shares of The Cigna Group during the third quarter valued at approximately $37,000. Collier Financial bought a new stake in The Cigna Group during the 4th quarter valued at $32,000. ORG Wealth Partners LLC bought a new stake in The Cigna Group during the 4th quarter valued at $34,000. Harbor Capital Advisors Inc. acquired a new position in The Cigna Group during the third quarter worth $45,000. Finally, Compagnie Lombard Odier SCmA bought a new position in shares of The Cigna Group in the fourth quarter valued at $37,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
CI has been the subject of several recent research reports. Royal Bank of Canada decreased their target price on shares of The Cigna Group from $384.00 to $377.00 and set an "outperform" rating for the company in a research report on Friday, November 1st. UBS Group lowered their price objective on The Cigna Group from $410.00 to $390.00 and set a "buy" rating for the company in a research note on Monday, February 3rd. Deutsche Bank Aktiengesellschaft cut their target price on The Cigna Group from $398.00 to $394.00 and set a "buy" rating on the stock in a research report on Monday, November 4th. Raymond James restated a "strong-buy" rating and set a $360.00 price objective (down from $415.00) on shares of The Cigna Group in a research note on Friday, January 31st. Finally, Cantor Fitzgerald reduced their target price on shares of The Cigna Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research note on Friday, January 31st. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Buy" and an average target price of $373.69.
Check Out Our Latest Report on The Cigna Group
The Cigna Group Stock Performance
NYSE CI traded up $0.24 on Friday, hitting $299.92. 2,213,736 shares of the stock traded hands, compared to its average volume of 1,806,507. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The business's fifty day moving average is $285.99 and its two-hundred day moving average is $319.78. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83. The firm has a market capitalization of $83.42 billion, a price-to-earnings ratio of 24.50, a PEG ratio of 0.98 and a beta of 0.54.
The Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the prior year, the company posted $6.79 EPS. As a group, equities analysts anticipate that The Cigna Group will post 29.77 EPS for the current fiscal year.
The Cigna Group Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th will be given a $1.51 dividend. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $6.04 annualized dividend and a dividend yield of 2.01%. This is a positive change from The Cigna Group's previous quarterly dividend of $1.40. The Cigna Group's payout ratio is 45.75%.
The Cigna Group Profile
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Articles

Before you consider The Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.
While The Cigna Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.